Private Wealth Asset Management, LLC Denali Therapeutics Inc. Transaction History
Private Wealth Asset Management, LLC
- $695 Billion
- Q1 2025
A detailed history of Private Wealth Asset Management, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Private Wealth Asset Management, LLC holds 38 shares of DNLI stock, worth $538. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38Holding current value
$538% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
124MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$187 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$171 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$167 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$162 Million0.03% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$75.8 Million0.37% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.9B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...